Ubs Group Ag Orasure Technologies Inc Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

A detailed history of Ubs Group Ag transactions in Orasure Technologies Inc stock. As of the latest transaction made, Ubs Group Ag holds 32,017 shares of OSUR stock, worth $115,901. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,017
Previous 43,832 26.96%
Holding current value
$115,901
Previous $186,000 26.88%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$3.93 - $4.59 $46,432 - $54,230
-11,815 Reduced 26.96%
32,017 $136,000
Q2 2024

Aug 13, 2024
SELL
$4.2 - $6.18 $116,671 - $171,674
-27,779 Reduced 38.79%
43,832 $186,000
Q1 2024

May 13, 2024
BUY
$6.08 - $8.28 $204,525 - $278,530
33,639 Added 88.59%
71,611 $440,000
Q4 2023

Feb 09, 2024
BUY
$5.13 - $8.35 $62,149 - $101,160
12,115 Added 46.85%
37,972 $311,000
Q3 2023

Nov 09, 2023
SELL
$4.4 - $6.91 $132,189 - $207,597
-30,043 Reduced 53.74%
25,857 $153,000
Q2 2023

Aug 11, 2023
BUY
$4.88 - $7.39 $124,347 - $188,304
25,481 Added 83.77%
55,900 $280,000
Q1 2023

May 12, 2023
SELL
$4.66 - $6.52 $39,153 - $54,781
-8,402 Reduced 21.64%
30,419 $184,000
Q4 2022

Feb 08, 2023
BUY
$3.7 - $5.29 $102,134 - $146,025
27,604 Added 246.09%
38,821 $187,000
Q3 2022

Nov 10, 2022
BUY
$2.72 - $4.61 $13,774 - $23,345
5,064 Added 82.3%
11,217 $42,000
Q2 2022

Aug 10, 2022
SELL
$2.71 - $7.12 $62,351 - $163,816
-23,008 Reduced 78.9%
6,153 $17,000
Q1 2022

May 16, 2022
SELL
$6.62 - $9.33 $186,266 - $262,518
-28,137 Reduced 49.11%
29,161 $197,000
Q4 2021

Feb 14, 2022
BUY
$8.3 - $11.29 $353,098 - $480,299
42,542 Added 288.3%
57,298 $498,000
Q3 2021

Nov 15, 2021
SELL
$9.73 - $13.38 $121,333 - $166,848
-12,470 Reduced 45.8%
14,756 $167,000
Q2 2021

Aug 13, 2021
SELL
$9.02 - $11.68 $161,611 - $209,270
-17,917 Reduced 39.69%
27,226 $276,000
Q1 2021

May 12, 2021
SELL
$9.53 - $15.42 $126,720 - $205,039
-13,297 Reduced 22.75%
45,143 $527,000
Q4 2020

Feb 11, 2021
BUY
$10.35 - $15.94 $110,351 - $169,952
10,662 Added 22.32%
58,440 $618,000
Q3 2020

Nov 12, 2020
BUY
$10.24 - $19.58 $28,098 - $53,727
2,744 Added 6.09%
47,778 $582,000
Q2 2020

Jul 31, 2020
SELL
$9.71 - $17.87 $3.37 Million - $6.2 Million
-347,111 Reduced 88.52%
45,034 $525,000
Q1 2020

May 01, 2020
SELL
$5.57 - $10.76 $151,509 - $292,682
-27,201 Reduced 6.49%
392,145 $4.22 Million
Q4 2019

Feb 14, 2020
BUY
$7.21 - $8.89 $2.67 Million - $3.29 Million
369,713 Added 744.89%
419,346 $3.37 Million
Q3 2019

Nov 14, 2019
BUY
$6.57 - $9.46 $238,247 - $343,047
36,263 Added 271.23%
49,633 $371,000
Q2 2019

Aug 14, 2019
BUY
$8.17 - $11.07 $76,887 - $104,179
9,411 Added 237.71%
13,370 $124,000
Q1 2019

May 14, 2019
SELL
$9.63 - $13.09 $212,986 - $289,511
-22,117 Reduced 84.82%
3,959 $44,000
Q4 2018

Feb 14, 2019
BUY
$10.53 - $15.54 $93,853 - $138,508
8,913 Added 51.93%
26,076 $304,000
Q3 2018

Nov 14, 2018
BUY
$15.25 - $17.72 $65,483 - $76,089
4,294 Added 33.37%
17,163 $265,000
Q2 2018

Aug 14, 2018
BUY
$14.46 - $18.08 $74,584 - $93,256
5,158 Added 66.89%
12,869 $212,000
Q1 2018

May 15, 2018
SELL
$16.77 - $22.04 $16,417 - $21,577
-979 Reduced 11.27%
7,711 $130,000
Q4 2017

Feb 14, 2018
SELL
$13.44 - $22.81 $78,583 - $133,370
-5,847 Reduced 40.22%
8,690 $163,000
Q3 2017

Nov 14, 2017
BUY
$19.97 - $22.74 $7,628 - $8,686
382 Added 2.7%
14,537 $327,000
Q2 2017

Aug 14, 2017
BUY
N/A
7,015 Added 98.25%
14,155 $244,000
Q1 2017

Nov 14, 2017
BUY
N/A
7,140
7,140 $93,000

Others Institutions Holding OSUR

# of Institutions
201
Shares Held
65.4M
Call Options Held
2.2K
Put Options Held
5.1K
View Full List

About ORASURE TECHNOLOGIES INC

OSUR Quotes by TradingView
  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $263M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email